title: Nicotine levels after IV nicotine and cigarette smoking in men.
abstract: There has been considerable interest in the pharmacodynamics and pharmacokinetics of nicotine and the influence of different routes of administration. However, these variables are often examined in separate studies, and there is less information about the temporal relation between subjective reports and plasma nicotine levels. This study examined the time course and magnitude of plasma nicotine levels and reports of subjective "high" in nicotine-dependent men after 12 or more hrs of abstinence. The effects of two doses of IV nicotine and two doses of nicotine from cigarette smoking were compared, and samples were collected at 2-min intervals. Plasma nicotine levels after smoking a high-nicotine cigarette were significantly greater than after either dose of IV nicotine (p < .001). However, Visual Analog Scale (VAS) ratings of "high" after both doses of IV nicotine and smoking a high-nicotine cigarette did not differ significantly, and followed a similar time course. After smoking a low-nicotine cigarette, VAS ratings of "high" were significantly lower than after either IV nicotine dose or smoking a high-nicotine cigarette (p < .001). Peak levels of "high" were reported within 2 min after IV nicotine administration and the onset of cigarette smoking. Then "high" ratings abruptly decreased, while plasma nicotine rose to peak levels within 4 to 6 min after IV nicotine and 12 to 14 min during cigarette smoking. Plasma nicotine levels did not appear to determine the magnitude or time course of subjective effects under these conditions.
authors: Alcohol and Drug Abuse Research Center, Harvard Medical School, USA. nmello@mclean.harvard.edu
authors: Nancy K
authors: NK
authors: Mello
authors: Mackenzie R
authors: MR
authors: Peltier
authors: Haley
authors: H
authors: Duncanson
mesh_terms: D000328:Adult; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009538:Nicotine / Q000008:administration & dosage / Q000097:blood*; D012907:Smoking / Q000097:blood*; D014026:Nicotiana
chemical_list: D009538:Nicotine
references: J Pharmacol Exp Ther. 2001 Dec;299(3):1056-65
references: 11714895
references: Exp Clin Psychopharmacol. 2000 Aug;8(3):326-32
references: 10975620
references: J Consult Clin Psychol. 1993 Oct;61(5):743-50
references: 8245272
references: Horm Behav. 2010 Jun;58(1):57-71
references: 19835877
references: J Neurosci. 2011 Jul 27;31(30):10891-902
references: 21795541
references: Neuropsychopharmacology. 2008 Mar;33(4):749-60
references: 17507912
references: Clin Pharmacol Ther. 1997 Oct;62(4):453-63
references: 9357397
references: Nicotine Tob Res. 2000 Feb;2(1):19-37
references: 11072438
references: J Pharmacol Exp Ther. 1996 Dec;279(3):1345-56
references: 8968359
references: Nature. 1998 Jan 8;391(6663):173-7
references: 9428762
references: JAMA. 1990 Apr 18;263(15):2049-50
references: 2319665
references: Psychopharmacology (Berl). 2001 Feb;154(1):76-84
references: 11292009
references: J Pharmacol Exp Ther. 1982 Feb;220(2):256-65
references: 7057391
references: NIDA Res Monogr. 1989;92:73-100
references: 2512504
references: Pharmacol Biochem Behav. 1984 Dec;21(6):903-12
references: 6522419
references: Biol Mass Spectrom. 1991 May;20(5):247-52
references: 1883864
references: Drug Alcohol Depend. 1999 Sep 1;56(2):99-107
references: 10482401
references: Psychopharmacology (Berl). 1996 Dec;128(3):221-6
references: 8972541
references: Psychopharmacology (Berl). 2003 Jan;165(3):280-90
references: 12434259
references: Annu Rev Pharmacol Toxicol. 2007;47:699-729
references: 17009926
references: J Pharmacol Exp Ther. 1999 Jan;288(1):188-97
references: 9862770
references: J Psychiatr Res. 2006 Aug;40(5):404-18
references: 15979645
references: J Pharmacol Exp Ther. 1985 Jul;234(1):1-12
references: 4009494
references: Mol Interv. 2004 Oct;4(5):285-95
references: 15471911
references: Biochem Pharmacol. 2007 Oct 15;74(8):1102-11
references: 17597586
references: Nicotine Tob Res. 1999 Dec;1(4):357-64
references: 11072433
references: Nicotine Tob Res. 2011 Jul;13(7):573-8
references: 21454913
references: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references: 19710631
references: Pharmacol Biochem Behav. 1984 Jun;20(6):965-71
references: 6463080
references: Drug Alcohol Depend. 1993 Jun;33(1):23-9
references: 8370337
references: Drug Alcohol Depend. 1991 Jun;28(1):3-48
references: 1679387
references: N Engl J Med. 2010 Jun 17;362(24):2295-303
references: 20554984
references: J Pharm Biomed Anal. 2000 Sep;23(4):653-61
references: 10975241
references: J Nucl Med. 1998 Dec;39(12):2048-54
references: 9867140
references: Psychopharmacology (Berl). 1992;107(2-3):352-8
references: 1615136
references: Drug Alcohol Depend. 2013 Apr 1;129(1-2):137-44
references: 23117126
references: Neuropsychopharmacology. 2005 Sep;30(9):1751-63
references: 15870834
references: Psychopharmacology (Berl). 1999 Nov;147(2):210-6
references: 10591889
references: Psychopharmacology (Berl). 2000 Jul;150(4):361-73
references: 10958077
references: J Pharmacol Exp Ther. 2001 Feb;296(2):486-94
references: 11160635
references: J Anal Toxicol. 2001 Jul-Aug;25(5):419-24
references: 11499900
references: Am J Psychiatry. 1998 Aug;155(8):1009-15
references: 9699686
references: Psychopharmacology (Berl). 2010 May;209(4):383-94
references: 20232056
references: J Chromatogr. 1981 Jan 2;222(1):61-70
references: 6783675
references: Psychopharmacology (Berl). 2010 May;209(4):291-302
references: 20309531
references: Neuroimage. 2005 Jul 15;26(4):1097-108
references: 15886020